• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools+
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • My account
    • Cart
    • Sign-in
2 Minute Medicine
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools+
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • My account
    • Cart
    • Sign-in
SUBSCRIBE
2 Minute Medicine
Subscribe
EvidencePulse™ by 2 Minute Medicine 2026 evidence scan 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... ↑ Try EvidencePulse™ Ask the evidence.
Get the signal.
Try it now → Physician-trained medical AI by 2 Minute Medicine
Home All Specialties Chronic Disease

Adding mask recommendation did not significantly reduce the SARS-CoV-2 infection rate

byDavid XiangandHarsh Shah
May 13, 2022
in Chronic Disease, Infectious Disease, Public Health
Reading Time: 3 mins read
Masks for personal protection for SARS-CoV-2 infection
Share on FacebookShare on Twitter

1. Adding a mask recommendation to other public measures did not reduce the SARS-Cov-2 infection by more than 50%.

2. Having a mask recommendation did not significantly alter the SARS-CoV-2 infection rate among mask wearers.

Evidence Rating Level: 1 (Excellent)

Study Rundown: Although many localities recommend masks in community settings to prevent the transmission of SARS-CoV-2, the World Health Organization has acknowledged the lack of evidence that wearing a mask protects healthy persons from SARS-CoV-2. Prior observational studies reported that mask use reduced risk for SARS-CoV-2, though surgical and cloth masks were grouped in preventive studies. Observational evidence also indicates that mask-wearing mitigates SARS-CoV-2 transmission, but there is a gap in knowledge as to whether a recommendation to wear a surgical mask when outside the home among others reduces wearers’ risk for SARS-CoV-2 infection in setting where public health measures were in effect but community mask-wearing was uncommon and not recommended. This study demonstrated that the recommendation to wear surgical masks did not significantly reduce the SARS-CoV-2 infection rate among wearers. This study was limited by factors such as inconclusive results, missing data, variable adherence, patient-reported findings on home tests, now blinding, and no assessment of whether masks could decrease transmission from mask wearers to others. Nevertheless, these study’s findings are significant, as they demonstrate that the recommendation to wear a mask did not reduce the incidence of SARS-CoV-2 infection in mask wearers, though the findings were inclusive and the trial did not address the effects of masks as a source control or as protection in settings where social distancing and other public measures are not in effect.

Click to read the study in AIM

Relevant Reading: The Role of Masks in Mitigating the SARS-CoV-2 Pandemic: Another Piece of the Puzzle

RELATED REPORTS

Lower levels of education and place of birth were associated with non-admission to the intensive care unit in Sweden during COVID-19 pandemic

2 Minute Medicine Rewind August 31, 2026

Hematologic inflammatory indices may predict prognosis in younger patients with COVID-19 but not older patients

In-Depth [randomized control trial]: This randomized control trial was conducted in Denmark between April and May 2020, studying a total of 4862 patients. Patients who were community-dwelling adults aged 18 years or older without current or prior symptoms or diagnosis of COVID-19 who reported being outside the home among others for at least 3 hours per day and who did not wear masks during their daily work were eligible for the study. Patients who were prior mask wearers for their daily work or had prior diagnoses of COVID-19 were excluded from the study. The primary outcome measured was SARS-CoV-2 infection, defined as a positive result on an oropharyngeal/nasal swab test for SARS-CoV-2, or a hospital-based diagnosis of SARS-CoV-2 infection or COVID-19. Outcomes of the primary analysis were assessed via the chi-square test and odds ratios and confidence limits were calculated using logistic regression. Based on the analysis, the between-group difference in infection with SARS-CoV-2 was negative 0.3% (95% Confidence Interval [CI], -1.2 to 0.4%; odds ratio, 0.82 [95% CI, 0.54 to 1.23]). Infection with SARS-CoV-2 occurred in 1.8% of participants who recommended masks and 2.1% of the control participants. When the analysis was repeated with multiple imputations for missing data due to loss to follow-up, there were similar results (OR 0.81, 95% CI 0.53 to 1.23). Overall, this study demonstrates the recommendation to wear a surgical mask when outside the home did not significantly reduce the incidence of SARS-CoV-2 infection in mask wearers in a setting where social distancing and other public health measures were in effect and community use of masks was uncommon.

Image: PD

©2022 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

Tags: CoronavirusCOVID-19covid-19 transmissionface maskmasksmedical masksSARS-CoV-2
Previous Post

Canadian Syncope Risk Score demonstrates international external validation

Next Post

BNT162b2 safe and efficacious in children 5 to 11 years of age

RelatedReports

Novel coronavirus identified from patients with pneumonia in Wuhan, China
Emergency

Lower levels of education and place of birth were associated with non-admission to the intensive care unit in Sweden during COVID-19 pandemic

September 1, 2026
Rivaroxaban likely reduces risk of recurrent stroke in specific subgroup of patients with embolic stroke of undetermined source
Weekly Rewinds

2 Minute Medicine Rewind August 31, 2026

August 31, 2026
Novel coronavirus identified from patients with pneumonia in Wuhan, China
Chronic Disease

Hematologic inflammatory indices may predict prognosis in younger patients with COVID-19 but not older patients

August 4, 2026
Elagolix with add-back hormone therapy effective in reducing fibroid-associated menstrual bleeding
Weekly Rewinds

2 Minute Medicine Rewind August 3rd, 2026

August 3, 2026
Next Post
Decreased expression of nasal ACE2 may be correlated with lower prevalence of COVID-19 in children

BNT162b2 safe and efficacious in children 5 to 11 years of age

Novel coronavirus identified from patients with pneumonia in Wuhan, China

Single-dose Ad26.COV2.S vaccine provides moderate protection against Covid-19 related outcomes

Decreased expression of nasal ACE2 may be correlated with lower prevalence of COVID-19 in children

Vaccination boosted immunity acquired from previous SARS-CoV-2 infection

EvidencePulse™ by 2 Minute Medicine 2026 evidence scan 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... ↑ Try EvidencePulse™ Get the signal. Try it now → Physician-trained medical AI by 2 Minute Medicine

2MM+ All Access

Full details →
$4.99 /month

3-day free trial · cancel anytime

  • ✓100+ physician-written reports
  • ✓EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters
Start 3-day free trial

Then $4.99/month. Manage renewal in your account.

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Nirsevimab (Beyfortus) may reduce severe respiratory syncytial virus infections among infants
  • An artificial intelligence (AI) tool achieved high diagnostic accuracy for the identification and prediction of sepsis
  • Use of long-acting broadly neutralizing antibodies may delay human immunodeficiency virus (HIV) rebound following discontinuation of antiretroviral therapy
License Content
Terms of Use | Disclaimer
Cookie Policy
Cleantalk Pixel
2MM+ All Access Full details →

The medical literature, distilled daily.

Monthly plan selected: $4.99 /month.

$4.99/month

3-day free trial · cancel anytime

Start 3-day free trial

Then $4.99/month. Manage renewal in your account.

Yearly plan selected: $49.90 /year.

$49.90/year

2 months free

Start 3-day free trial

Then $49.90/year.

Membership benefits

  • ✓100+ physician-written reports
  • ✓AI EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters

Already a member? Sign in

  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • My account
    • Cart
    • Sign-in
No Result
View All Result

© 2026 2 Minute Medicine, Inc. - Physician-written medical news.